African countries are working together to enhance medicine use

Amos Massele, Daniel Afrivie, Johanita Burger, Charles Ezenduka, Joseph Fadare, Aubrey Kalungia, Dan Kibuule, Joanne Meyer, Olayinka Ogunleye, Margaret Oluka, Ilse Truter, Brian Godman

Research output: Contribution to conferenceAbstract

Abstract

Growing burden of infectious and NCDs across Africa, e.g. 70% of world’s HIV patients live in sub-Sahara Africa and 30 to 45% of adults have hypertension. This requires groups to collaborate. This is happening, e.g. SAHTAS, PharfA and MURIA. MURIA is researching antibiotic use, adherence to medicines and strengthening DTCs. This should continue to optimise medicine use and scarce resources. The socioeconomic burden of diseases is increasing in Africa. For instance in 2011, 70% of the world’s HIV population resided in sub-Sahara Africa. There are also growing rates of AMR, which necessitates newer more expensive antibiotics adding to costs. There is also a growing burden of NCDs, 3 out of 4 patients with hypertension currently live in LMICs, with prevalence rates up to 30% to 45% among adults in Africa. Alongside this, up to 70% of total healthcare expenditure is spent on medicines in LMICs; much of this out-of-pocket. Consequently, an urgent need to strengthen collaborative research to improve medicine use. Summary of groups working together in Africa including the Medicines Utilisation Research in Africa (MURIA) group. African Strategies for Health identifies and advocates best practices, as well as works with others to develop sustainable solutions. Pharmacology for Africa (PharfA) organises and promotes pharmacology on the African continent, including research in clinical pharmacology, alongside the IUPHAR sub-division. ISPOR Africa co-ordinates activities from the different African country chapters. SAHTAS is a scientific and professional society for all those who produce, use, or encounter HTA in Southern Africa, and WHO International and Regional groups are improving antibiotic drug utilisation capabilities in Africa. The MURIA group was established in 2015 [1]. Ongoing collaborative research includes (i) initiatives to optimise antibiotic use; (ii) methods to enhance adherence to anti-infective prescribing guidance, (iii) approaches to improve adherence to HIV and NCDs; (iv) researching current anti-hypertensive and anti-diabetes medicines utilisation patterns and knowledge; (v) approaches to enhance DTC activities, and (vi) strengthening medicine utilisation capabilities [2,3]. These activities have already strengthened research ties across Africa. A number of groups are already working across Africa to enhance appropriate medicine use, and should continue. Ongoing MURIA activities include antibiotic point-prevalence studies, ongoing research into infectious diseases, NCDs and DTCs including adherence as well as the third workshop and symposium in Namibia in 2017.
LanguageEnglish
Number of pages1
Publication statusAccepted/In press - 6 Mar 2017
EventHTAi’s 14th Annual Meeting - Rome, Italy
Duration: 17 Jun 201721 Jun 2017
Conference number: 14th

Conference

ConferenceHTAi’s 14th Annual Meeting
Abbreviated titleHTAiRome2017
CountryItaly
CityRome
Period17/06/1721/06/17

Fingerprint

Medicine
Research
Anti-Bacterial Agents
Northern Africa
HIV
Pharmacology
Namibia
Hypertension
Drug Utilization
Southern Africa
Clinical Pharmacology
Health Expenditures
Practice Guidelines
Antihypertensive Agents
Communicable Diseases
Cross-Sectional Studies
Delivery of Health Care
Education
Costs and Cost Analysis

Keywords

  • HIV
  • health in Africa
  • MURIA

Cite this

Massele, A., Afrivie, D., Burger, J., Ezenduka, C., Fadare, J., Kalungia, A., ... Godman, B. (Accepted/In press). African countries are working together to enhance medicine use. Abstract from HTAi’s 14th Annual Meeting, Rome, Italy.
Massele, Amos ; Afrivie, Daniel ; Burger, Johanita ; Ezenduka, Charles ; Fadare, Joseph ; Kalungia, Aubrey ; Kibuule, Dan ; Meyer, Joanne ; Ogunleye, Olayinka ; Oluka, Margaret ; Truter, Ilse ; Godman, Brian. / African countries are working together to enhance medicine use. Abstract from HTAi’s 14th Annual Meeting, Rome, Italy.1 p.
@conference{97d7d6310a454f24bbd6699a03c73c19,
title = "African countries are working together to enhance medicine use",
abstract = "Growing burden of infectious and NCDs across Africa, e.g. 70{\%} of world’s HIV patients live in sub-Sahara Africa and 30 to 45{\%} of adults have hypertension. This requires groups to collaborate. This is happening, e.g. SAHTAS, PharfA and MURIA. MURIA is researching antibiotic use, adherence to medicines and strengthening DTCs. This should continue to optimise medicine use and scarce resources. The socioeconomic burden of diseases is increasing in Africa. For instance in 2011, 70{\%} of the world’s HIV population resided in sub-Sahara Africa. There are also growing rates of AMR, which necessitates newer more expensive antibiotics adding to costs. There is also a growing burden of NCDs, 3 out of 4 patients with hypertension currently live in LMICs, with prevalence rates up to 30{\%} to 45{\%} among adults in Africa. Alongside this, up to 70{\%} of total healthcare expenditure is spent on medicines in LMICs; much of this out-of-pocket. Consequently, an urgent need to strengthen collaborative research to improve medicine use. Summary of groups working together in Africa including the Medicines Utilisation Research in Africa (MURIA) group. African Strategies for Health identifies and advocates best practices, as well as works with others to develop sustainable solutions. Pharmacology for Africa (PharfA) organises and promotes pharmacology on the African continent, including research in clinical pharmacology, alongside the IUPHAR sub-division. ISPOR Africa co-ordinates activities from the different African country chapters. SAHTAS is a scientific and professional society for all those who produce, use, or encounter HTA in Southern Africa, and WHO International and Regional groups are improving antibiotic drug utilisation capabilities in Africa. The MURIA group was established in 2015 [1]. Ongoing collaborative research includes (i) initiatives to optimise antibiotic use; (ii) methods to enhance adherence to anti-infective prescribing guidance, (iii) approaches to improve adherence to HIV and NCDs; (iv) researching current anti-hypertensive and anti-diabetes medicines utilisation patterns and knowledge; (v) approaches to enhance DTC activities, and (vi) strengthening medicine utilisation capabilities [2,3]. These activities have already strengthened research ties across Africa. A number of groups are already working across Africa to enhance appropriate medicine use, and should continue. Ongoing MURIA activities include antibiotic point-prevalence studies, ongoing research into infectious diseases, NCDs and DTCs including adherence as well as the third workshop and symposium in Namibia in 2017.",
keywords = "HIV, health in Africa, MURIA",
author = "Amos Massele and Daniel Afrivie and Johanita Burger and Charles Ezenduka and Joseph Fadare and Aubrey Kalungia and Dan Kibuule and Joanne Meyer and Olayinka Ogunleye and Margaret Oluka and Ilse Truter and Brian Godman",
year = "2017",
month = "3",
day = "6",
language = "English",
note = "HTAi’s 14th Annual Meeting, HTAiRome2017 ; Conference date: 17-06-2017 Through 21-06-2017",

}

Massele, A, Afrivie, D, Burger, J, Ezenduka, C, Fadare, J, Kalungia, A, Kibuule, D, Meyer, J, Ogunleye, O, Oluka, M, Truter, I & Godman, B 2017, 'African countries are working together to enhance medicine use' HTAi’s 14th Annual Meeting, Rome, Italy, 17/06/17 - 21/06/17, .

African countries are working together to enhance medicine use. / Massele, Amos; Afrivie, Daniel; Burger, Johanita; Ezenduka, Charles; Fadare, Joseph; Kalungia, Aubrey; Kibuule, Dan; Meyer, Joanne; Ogunleye, Olayinka; Oluka, Margaret; Truter, Ilse; Godman, Brian.

2017. Abstract from HTAi’s 14th Annual Meeting, Rome, Italy.

Research output: Contribution to conferenceAbstract

TY - CONF

T1 - African countries are working together to enhance medicine use

AU - Massele, Amos

AU - Afrivie, Daniel

AU - Burger, Johanita

AU - Ezenduka, Charles

AU - Fadare, Joseph

AU - Kalungia, Aubrey

AU - Kibuule, Dan

AU - Meyer, Joanne

AU - Ogunleye, Olayinka

AU - Oluka, Margaret

AU - Truter, Ilse

AU - Godman, Brian

PY - 2017/3/6

Y1 - 2017/3/6

N2 - Growing burden of infectious and NCDs across Africa, e.g. 70% of world’s HIV patients live in sub-Sahara Africa and 30 to 45% of adults have hypertension. This requires groups to collaborate. This is happening, e.g. SAHTAS, PharfA and MURIA. MURIA is researching antibiotic use, adherence to medicines and strengthening DTCs. This should continue to optimise medicine use and scarce resources. The socioeconomic burden of diseases is increasing in Africa. For instance in 2011, 70% of the world’s HIV population resided in sub-Sahara Africa. There are also growing rates of AMR, which necessitates newer more expensive antibiotics adding to costs. There is also a growing burden of NCDs, 3 out of 4 patients with hypertension currently live in LMICs, with prevalence rates up to 30% to 45% among adults in Africa. Alongside this, up to 70% of total healthcare expenditure is spent on medicines in LMICs; much of this out-of-pocket. Consequently, an urgent need to strengthen collaborative research to improve medicine use. Summary of groups working together in Africa including the Medicines Utilisation Research in Africa (MURIA) group. African Strategies for Health identifies and advocates best practices, as well as works with others to develop sustainable solutions. Pharmacology for Africa (PharfA) organises and promotes pharmacology on the African continent, including research in clinical pharmacology, alongside the IUPHAR sub-division. ISPOR Africa co-ordinates activities from the different African country chapters. SAHTAS is a scientific and professional society for all those who produce, use, or encounter HTA in Southern Africa, and WHO International and Regional groups are improving antibiotic drug utilisation capabilities in Africa. The MURIA group was established in 2015 [1]. Ongoing collaborative research includes (i) initiatives to optimise antibiotic use; (ii) methods to enhance adherence to anti-infective prescribing guidance, (iii) approaches to improve adherence to HIV and NCDs; (iv) researching current anti-hypertensive and anti-diabetes medicines utilisation patterns and knowledge; (v) approaches to enhance DTC activities, and (vi) strengthening medicine utilisation capabilities [2,3]. These activities have already strengthened research ties across Africa. A number of groups are already working across Africa to enhance appropriate medicine use, and should continue. Ongoing MURIA activities include antibiotic point-prevalence studies, ongoing research into infectious diseases, NCDs and DTCs including adherence as well as the third workshop and symposium in Namibia in 2017.

AB - Growing burden of infectious and NCDs across Africa, e.g. 70% of world’s HIV patients live in sub-Sahara Africa and 30 to 45% of adults have hypertension. This requires groups to collaborate. This is happening, e.g. SAHTAS, PharfA and MURIA. MURIA is researching antibiotic use, adherence to medicines and strengthening DTCs. This should continue to optimise medicine use and scarce resources. The socioeconomic burden of diseases is increasing in Africa. For instance in 2011, 70% of the world’s HIV population resided in sub-Sahara Africa. There are also growing rates of AMR, which necessitates newer more expensive antibiotics adding to costs. There is also a growing burden of NCDs, 3 out of 4 patients with hypertension currently live in LMICs, with prevalence rates up to 30% to 45% among adults in Africa. Alongside this, up to 70% of total healthcare expenditure is spent on medicines in LMICs; much of this out-of-pocket. Consequently, an urgent need to strengthen collaborative research to improve medicine use. Summary of groups working together in Africa including the Medicines Utilisation Research in Africa (MURIA) group. African Strategies for Health identifies and advocates best practices, as well as works with others to develop sustainable solutions. Pharmacology for Africa (PharfA) organises and promotes pharmacology on the African continent, including research in clinical pharmacology, alongside the IUPHAR sub-division. ISPOR Africa co-ordinates activities from the different African country chapters. SAHTAS is a scientific and professional society for all those who produce, use, or encounter HTA in Southern Africa, and WHO International and Regional groups are improving antibiotic drug utilisation capabilities in Africa. The MURIA group was established in 2015 [1]. Ongoing collaborative research includes (i) initiatives to optimise antibiotic use; (ii) methods to enhance adherence to anti-infective prescribing guidance, (iii) approaches to improve adherence to HIV and NCDs; (iv) researching current anti-hypertensive and anti-diabetes medicines utilisation patterns and knowledge; (v) approaches to enhance DTC activities, and (vi) strengthening medicine utilisation capabilities [2,3]. These activities have already strengthened research ties across Africa. A number of groups are already working across Africa to enhance appropriate medicine use, and should continue. Ongoing MURIA activities include antibiotic point-prevalence studies, ongoing research into infectious diseases, NCDs and DTCs including adherence as well as the third workshop and symposium in Namibia in 2017.

KW - HIV

KW - health in Africa

KW - MURIA

UR - http://www.htai2017.org/

M3 - Abstract

ER -

Massele A, Afrivie D, Burger J, Ezenduka C, Fadare J, Kalungia A et al. African countries are working together to enhance medicine use. 2017. Abstract from HTAi’s 14th Annual Meeting, Rome, Italy.